Business Today
Loading...

Share Market Highlights: Sensex ends at record high, Nifty at 14,132; TCS, HUL, ONGC, M&M, L&T top gainers

January 04,2021 17:16 IST

Sensex, Nifty Highlights on January 4: Market indices continued to surge to new record highs on Monday for the ninth straight session, after Drugs Controller General of India (DCGI) granted restricted emergency use authorisation for the Serum Institute of India (SII)'s 'Covishield' and Bharat Biotech's 'Covaxin' vaccines against COVID-19 in India. In line with positive global equities, Sensex ended 307 points higher at 48,176 and Nifty gained by 114 points higher at 14,132. During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147

 

 

 

Check Latest Updates

  • India Stock Market Highlights Today: TCS, ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank were among the gainers
  • Jan 04, 2021 15:53 (IST)

    Closing session

    Market indices continued to surge to new record highs on Monday for the ninth straight session, after Drugs Controller General of India (DCGI) granted restricted emergency use authorisation for the Serum Institute of India (SII)'s 'Covishield' and Bharat Biotech's 'Covaxin' vaccines against COVID-19 in India. In line with positive global equities, Sensex ended 307 points higher at 48,176 and Nifty gained by 114 points higher at 14,132. During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147

     

  • 15:53 IST: Market indices continued to surge to new record highs on Monday for the ninth straight session, after Drugs Controller General of India (DCGI) granted restricted emergency use authorisation for the Serum Institute of India (SII)'s 'Covishield' and Bharat Biotech's 'Covaxin' vaccines against COVID-19 in India. In line with positive global equities, Sensex ended 307 points higher at 48,176 and Nifty gained by 114 points higher at 14,132. During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147

     

  • Jan 04, 2021 15:49 (IST)

    Jindal Steel share jumps to new high




    Jindal Steel & Power (JSPL) share rose over 6% to hit a new high of Rs 288 on Monday after the firm  posted a record 30% jump in its standalone production and 25% growth in sales during December 2020.

    Jindal Steel stock touched an intraday high of Rs 288, gaining up to 6.55% on BSE, also its new 52-week high. The stock has gained 10.8% in last four consecutive days.


    The private steel maker's total production from its plants in India stood at 7.27 lakh tonne (LT) for the month of December, as compared to 5.59 LT during the same month last year
     

  • 15:49 IST:


    Jindal Steel & Power (JSPL) share rose over 6% to hit a new high of Rs 288 on Monday after the firm  posted a record 30% jump in its standalone production and 25% growth in sales during December 2020.

    Jindal Steel stock touched an intraday high of Rs 288, gaining up to 6.55% on BSE, also its new 52-week high. The stock has gained 10.8% in last four consecutive days.


    The private steel maker's total production from its plants in India stood at 7.27 lakh tonne (LT) for the month of December, as compared to 5.59 LT during the same month last year
     

  • Jan 04, 2021 15:44 (IST)

    M&M December sales numbers





    Jyoti Roy - DVP- Equity Strategist, Angel Broking said," M&M reported mixed monthly sales numbers for December 2020. Tractor sales for the month registered a growth of 25% YoY to 22,417 units led by strong growth in both domestic sales and exports. However the automotive division registered a degrowth of 10.3% YoY to 35,187 units.The domestic PV segment registered a growth of 3% YoY to 16182 units while CV segment registered a degrowth of 47% YoY to 2865 units. Export for the month of December was up by 2210 units. While the tractor segment continues to remain a bright spot for M7M the CV business continues to act as a drag on the overall sales numbers."

  • 15:44 IST:



    Jyoti Roy - DVP- Equity Strategist, Angel Broking said," M&M reported mixed monthly sales numbers for December 2020. Tractor sales for the month registered a growth of 25% YoY to 22,417 units led by strong growth in both domestic sales and exports. However the automotive division registered a degrowth of 10.3% YoY to 35,187 units.The domestic PV segment registered a growth of 3% YoY to 16182 units while CV segment registered a degrowth of 47% YoY to 2865 units. Export for the month of December was up by 2210 units. While the tractor segment continues to remain a bright spot for M7M the CV business continues to act as a drag on the overall sales numbers."

  • Jan 04, 2021 15:39 (IST)

    Market hits new high

    During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147

  • 15:39 IST: During today's session, Sensex hit a lifetime high of 48,220 and Nifty rose to a new high of 14,147

  • Jan 04, 2021 15:36 (IST)

    BEML share rises 8%

    BEML share rose nearly 8% today after the Modi government sought expression of interests (EoI) from domestic and foreign players for disinvestment in the PSU firm. The share of manufacturer of variety of heavy equipments opened with a gain of 7.78% today at Rs 1,050, also its intra day high against previous close of Rs 974.25 on BSE.

    BEML share is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.

    The stock has gained 5% in three days. The share has gained 3.55% in one year and risen 4.23% since the beginning of this year.

    BEML share rises 8% after govt seeks initial bids for divestment

  • 15:36 IST: BEML share rose nearly 8% today after the Modi government sought expression of interests (EoI) from domestic and foreign players for disinvestment in the PSU firm. The share of manufacturer of variety of heavy equipments opened with a gain of 7.78% today at Rs 1,050, also its intra day high against previous close of Rs 974.25 on BSE.

    BEML share is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.

    The stock has gained 5% in three days. The share has gained 3.55% in one year and risen 4.23% since the beginning of this year.

    BEML share rises 8% after govt seeks initial bids for divestment

  • Jan 04, 2021 15:26 (IST)

    Maruti Suzuki December 2020 sales numbers




    Jyoti Roy - DVP- Equity Strategist, Angel Broking said,"Maruti Suzuki reported better than expected sales numbers for the month of December 2020. Total sales for the month of December was up by 20.2% yoy to 1,60,226 units. Domestic sales for the month were up by 17.8% to 1,46,480 units while exports also registered a strong growth of 31.4% YoY to 9,938 units. Domestic sales growth was driven by the compact and the LCV segments which grew by 18.2% and 259.9% respectively. The mid level segment continued to struggle and registered a degrowth of 28.9% YoY. Utility vehicles and vans reported decent growth of 8.0% and 46.9% respectively. Overall the numbers are very encouraging and point to continued strong demand in the PV segment."

     

  • 15:26 IST:


    Jyoti Roy - DVP- Equity Strategist, Angel Broking said,"Maruti Suzuki reported better than expected sales numbers for the month of December 2020. Total sales for the month of December was up by 20.2% yoy to 1,60,226 units. Domestic sales for the month were up by 17.8% to 1,46,480 units while exports also registered a strong growth of 31.4% YoY to 9,938 units. Domestic sales growth was driven by the compact and the LCV segments which grew by 18.2% and 259.9% respectively. The mid level segment continued to struggle and registered a degrowth of 28.9% YoY. Utility vehicles and vans reported decent growth of 8.0% and 46.9% respectively. Overall the numbers are very encouraging and point to continued strong demand in the PV segment."

     

  • Jan 04, 2021 15:18 (IST)

    Gold and silver outlook

    Anuj Gupta- DVP- Commodities and Currencies Research, Angel Broking said," Last week, Spot Gold prices ended higher by 1.1 percent as confirmation on the additional stimulus by U.S. weighed on the Dollar making the yellow metal cheaper for other currency holders. Inflations worries and a low interest rate environment has kept Gold prices elevated as it is considered as a hedge. Moreover, worsening of the global economic scenario and mounting worries over the new virus strain which was detected in UK also boosted demand for the safe haven, Gold. However, the U.S. Senate set to vote on a $2,000 COVID-19 relief checks instead of $600 amid the European COVID-19 vaccination drive dented appeal for the safe haven, Gold

     

    Last week, Spot silver prices gained about 2 percent to close at $26.4 per ounce while Silver prices on the MCX ended higher by 1 percent closing at Rs.68105 per kg.

     

    Mounting worries over the impact of the never ending pandemic is expected to boost the demand for the safe haven, Gold. On the MCX, gold prices are expected to trade higher in today’s session.

     

     

    As for today traders can go for BUY in gold at Rs 50500 levels with the stop loss of Rs 50200 levels for the target   of 51300 levels. They can also go for BUY  in Silver at Rs 69000 levels, with the stop loss of 68000 levels and for the target of 70500 levels. We expect gold may test $1940 levels and silver may test $28 levels soon."
     

  • 15:18 IST: Anuj Gupta- DVP- Commodities and Currencies Research, Angel Broking said," Last week, Spot Gold prices ended higher by 1.1 percent as confirmation on the additional stimulus by U.S. weighed on the Dollar making the yellow metal cheaper for other currency holders. Inflations worries and a low interest rate environment has kept Gold prices elevated as it is considered as a hedge. Moreover, worsening of the global economic scenario and mounting worries over the new virus strain which was detected in UK also boosted demand for the safe haven, Gold. However, the U.S. Senate set to vote on a $2,000 COVID-19 relief checks instead of $600 amid the European COVID-19 vaccination drive dented appeal for the safe haven, Gold

     

    Last week, Spot silver prices gained about 2 percent to close at $26.4 per ounce while Silver prices on the MCX ended higher by 1 percent closing at Rs.68105 per kg.

     

    Mounting worries over the impact of the never ending pandemic is expected to boost the demand for the safe haven, Gold. On the MCX, gold prices are expected to trade higher in today’s session.

     

     

    As for today traders can go for BUY in gold at Rs 50500 levels with the stop loss of Rs 50200 levels for the target   of 51300 levels. They can also go for BUY  in Silver at Rs 69000 levels, with the stop loss of 68000 levels and for the target of 70500 levels. We expect gold may test $1940 levels and silver may test $28 levels soon."
     

  • Jan 04, 2021 14:53 (IST)

    Nifty technical outlook

    Sameet Chavan (Chief Analyst-Technical and Derivatives, Angel Broking) said,"The mankind had to witness a lot of unprecedented things in the year gone by. Initially it was very difficult to adjust with the forceful changes in our lives; but we always try to make our own ways in all the difficulties and this is exactly what has been proven all these months. The year 2020 was full of shocks and surprises; but as we always say "All's well that ends well". We not only stabilized from the March chaos but also managed to give a stupendous v-shaped recovery in the last nine months to even surpass pre-COVID highs with some authority.

    During the concluding week of the calendar year, Nifty added another couple of percent to Bulls' kitty and importantly reached yet another milestone of 14000. Now, there are lots of expectations built as we step into the New Year. With a broader view, there is no brainer, we are heading for much bigger levels from here on; but it would be unfair to expect the similar kind of linear move that we have been enjoying since early November. In between, markets are likely to give some corrections, which would be a healthy sign. For this week, we expect the Nifty to slowly and gradually head towards 14150-14200; whereas the key support zone is placed at 13950 - 13850 levels."

  • 14:53 IST: Sameet Chavan (Chief Analyst-Technical and Derivatives, Angel Broking) said,"The mankind had to witness a lot of unprecedented things in the year gone by. Initially it was very difficult to adjust with the forceful changes in our lives; but we always try to make our own ways in all the difficulties and this is exactly what has been proven all these months. The year 2020 was full of shocks and surprises; but as we always say "All's well that ends well". We not only stabilized from the March chaos but also managed to give a stupendous v-shaped recovery in the last nine months to even surpass pre-COVID highs with some authority.

    During the concluding week of the calendar year, Nifty added another couple of percent to Bulls' kitty and importantly reached yet another milestone of 14000. Now, there are lots of expectations built as we step into the New Year. With a broader view, there is no brainer, we are heading for much bigger levels from here on; but it would be unfair to expect the similar kind of linear move that we have been enjoying since early November. In between, markets are likely to give some corrections, which would be a healthy sign. For this week, we expect the Nifty to slowly and gradually head towards 14150-14200; whereas the key support zone is placed at 13950 - 13850 levels."

  • Jan 04, 2021 14:46 (IST)

    Escort stock outlook

    Amarjeet Maurya - AVP - Mid Caps, Angel Broking said," In December 20, Escort reported total tractor sales number ~88% yoy growth to 7,733. On the domestic front, Escort reported ~90% yoy growth in tractor sales number which is better than expected. For period 9MFY21, the company has reported ~12% growth yoy in domestic tractor sales number. Going forward all macroeconomic factors remain in favour of continued growth and we do not expect any significant supply-demand gaps."
     

  • 14:46 IST: Amarjeet Maurya - AVP - Mid Caps, Angel Broking said," In December 20, Escort reported total tractor sales number ~88% yoy growth to 7,733. On the domestic front, Escort reported ~90% yoy growth in tractor sales number which is better than expected. For period 9MFY21, the company has reported ~12% growth yoy in domestic tractor sales number. Going forward all macroeconomic factors remain in favour of continued growth and we do not expect any significant supply-demand gaps."
     

  • Jan 04, 2021 14:36 (IST)

    Cadila stock outlook

    Yash Gupta Equity Research Associate, Angel Broking said," Cadila stock was up by 1.29% after the firm received approvals from the DCGI to start PhCadilase Ill Clinical Trial of ZyCoV-D — fully indigenously developed vaccine. Zydus Cadila announced that it will be starting Phase III clinical trials of its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D after having received permissions from the DCGI. The company will now be initiating Phase III clinical trial in around 30,000 volunteers. ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials. The Phase II study of the vaccine ZyCoV-D had been conducted in over 1000 healthy adult volunteers as part of the adaptive Phase I/II dose escalation, multi-centric, randomized, double-blind placebo controlled study. The vaccine was found to be safe and elicit a strong immunogenic response. The trial has reviewed by an independent Data Safety Monitoring Board (DSMB) and reports were submitted to Central Drugs Standard Control Organisation (CDSCO) regularly for the update on safety outcome. This is a very positive development for the company, 3rd phase of human trials will take 3-4 months so we can expect some development in April 2021."

  • 14:36 IST: Yash Gupta Equity Research Associate, Angel Broking said," Cadila stock was up by 1.29% after the firm received approvals from the DCGI to start PhCadilase Ill Clinical Trial of ZyCoV-D — fully indigenously developed vaccine. Zydus Cadila announced that it will be starting Phase III clinical trials of its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D after having received permissions from the DCGI. The company will now be initiating Phase III clinical trial in around 30,000 volunteers. ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials. The Phase II study of the vaccine ZyCoV-D had been conducted in over 1000 healthy adult volunteers as part of the adaptive Phase I/II dose escalation, multi-centric, randomized, double-blind placebo controlled study. The vaccine was found to be safe and elicit a strong immunogenic response. The trial has reviewed by an independent Data Safety Monitoring Board (DSMB) and reports were submitted to Central Drugs Standard Control Organisation (CDSCO) regularly for the update on safety outcome. This is a very positive development for the company, 3rd phase of human trials will take 3-4 months so we can expect some development in April 2021."

  • Jan 04, 2021 14:20 (IST)

    Cadila Healthcare share rises 3%

    Cadila Healthcare share rose over 3% today after  regulator Drugs Controller General of India (DCGI) gave its nod to Phase III clinical trials of the Ahmedabad-based company's Covid-19 vaccine ZyCoV-D. Csdila Healthcare share touched an intraday high of Rs 492.95, rising 3.02% against previous close of Rs 478.50 on BSE.

    Cadila Healthcare share rises 3% on DCGI nod to Phase III trial of COVID-19 vaccine

  • 14:20 IST: Cadila Healthcare share rose over 3% today after  regulator Drugs Controller General of India (DCGI) gave its nod to Phase III clinical trials of the Ahmedabad-based company's Covid-19 vaccine ZyCoV-D. Csdila Healthcare share touched an intraday high of Rs 492.95, rising 3.02% against previous close of Rs 478.50 on BSE.

    Cadila Healthcare share rises 3% on DCGI nod to Phase III trial of COVID-19 vaccine

  • Jan 04, 2021 14:17 (IST)

    Market at new highs

    During today's session, Sensex hit a lifetime high of 48,168 and Nifty rose to a new high of 14,116.

  • 14:17 IST: During today's session, Sensex hit a lifetime high of 48,168 and Nifty rose to a new high of 14,116.

  • Jan 04, 2021 14:14 (IST)

    Outlook 2021 for Real Estate sector



    Kapil Kapur, Director – Sales & Strategy, Bullmen Realty, said “The year of 2021 brings with itself new opportunities for recovery in real estate. With country's major real estate market like MMR breaking records in sales, other real estate markets are also likely to follow the suit post support from government policies such as the stamp duty reduction. Barring that, the sales will only be influenced by end-users' interest and low home loan interest rates. With offices resuming partially, the commercial segment with upgraded tech-based systems is likely to rule the roost in a post-pandemic world. This year will be a testing time to see how persistent the new consumer trends will be, once vaccination begins and people become accustomed to living, working and socializing in the new normal.”

  • 14:14 IST:

    Kapil Kapur, Director – Sales & Strategy, Bullmen Realty, said “The year of 2021 brings with itself new opportunities for recovery in real estate. With country's major real estate market like MMR breaking records in sales, other real estate markets are also likely to follow the suit post support from government policies such as the stamp duty reduction. Barring that, the sales will only be influenced by end-users' interest and low home loan interest rates. With offices resuming partially, the commercial segment with upgraded tech-based systems is likely to rule the roost in a post-pandemic world. This year will be a testing time to see how persistent the new consumer trends will be, once vaccination begins and people become accustomed to living, working and socializing in the new normal.”

  • Jan 04, 2021 14:00 (IST)

    NMDC share rises over 5%

    NMDC share gained over 5% in early trade today after the firm reported a 23.3% rise in December iron ore production. The share touched an intraday high of Rs 122.3, rising 5.11% against previous close of  Rs 116.35. The stock has gained 6.6% in the last 2 days. Total 7.67 lakh shares of the firm changed hands on BSE.

    NMDC share is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The large cap share has lost 5.61% in one year and gained 6.6% since the beginning of this year.

    In a month, the share has climbed 14.24%.

    NMDC share rises over 5% as firm logs 23% increase in iron ore output

  • 14:00 IST: NMDC share gained over 5% in early trade today after the firm reported a 23.3% rise in December iron ore production. The share touched an intraday high of Rs 122.3, rising 5.11% against previous close of  Rs 116.35. The stock has gained 6.6% in the last 2 days. Total 7.67 lakh shares of the firm changed hands on BSE.

    NMDC share is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages. The large cap share has lost 5.61% in one year and gained 6.6% since the beginning of this year.

    In a month, the share has climbed 14.24%.

    NMDC share rises over 5% as firm logs 23% increase in iron ore output

  • Jan 04, 2021 13:51 (IST)

    Gold prices reach 8-week high; surpass $1,900

    Gold prices started the new year on a high by notching an eight-week peak after surpassing the key $1,900 level on Monday, as a surge in COVID-19 cases and prospects of tougher coronavirus control measures lured investors to the safe-haven metal. Spot gold rose 1.1% to $1,919.07 per ounce by 0246 GMT, having hit its highest since Nov. 9 at $1,920.09, while US gold futures climbed 1.5% to $1,923.50.

    Gold prices reach 8-week high; surpass $1,900

  • 13:51 IST: Gold prices started the new year on a high by notching an eight-week peak after surpassing the key $1,900 level on Monday, as a surge in COVID-19 cases and prospects of tougher coronavirus control measures lured investors to the safe-haven metal. Spot gold rose 1.1% to $1,919.07 per ounce by 0246 GMT, having hit its highest since Nov. 9 at $1,920.09, while US gold futures climbed 1.5% to $1,923.50.

    Gold prices reach 8-week high; surpass $1,900

  • Jan 04, 2021 13:40 (IST)

    Global markets bouyed today


    As the first trading day of 2021 kicked off, markets globally were buoyed today.Key economic data out of China and Japan kept sentiments upbeat. A business survey on Monday showed that activity growth in China's vast industrial sector had slowed, raising doubts about a ift global economic rebound.

    Further, the final au Jibun Bank Japan Manufacturing Purchasing Managers' Index (PMI) rose to a seasonally adjusted 50.0 in December from the previous month's 49.0 and a preliminary 49.7 reading.


    Investors also looked forward to data from the United States and Europe that is due later in the day and cautiously awaited runoff elections outcome in Georgia for two U.S. Senate seats, scheduled on Tuesday that will determine which party controls the Senate.

     

  • 13:40 IST:
    As the first trading day of 2021 kicked off, markets globally were buoyed today.Key economic data out of China and Japan kept sentiments upbeat. A business survey on Monday showed that activity growth in China's vast industrial sector had slowed, raising doubts about a ift global economic rebound.

    Further, the final au Jibun Bank Japan Manufacturing Purchasing Managers' Index (PMI) rose to a seasonally adjusted 50.0 in December from the previous month's 49.0 and a preliminary 49.7 reading.


    Investors also looked forward to data from the United States and Europe that is due later in the day and cautiously awaited runoff elections outcome in Georgia for two U.S. Senate seats, scheduled on Tuesday that will determine which party controls the Senate.

     

  • Jan 04, 2021 13:32 (IST)

    Rupee surges 21 paise to 72.90

    Indian rupee appreciated by 21 paise to 72.90 against the US dollar on Monday's opening trade supported by sustained foreign fund inflows and weakness of the American currency in the overseas market. Positive domestic equities and news on COVID-19 vaccine also improved sentiments.

    India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

    The domestic unit opened at 72.93 against the US dollar at the interbank forex market, and inched higher to 72.90

    Rupee surges 21 paise to 72.90 amid weak US dollar, positive domestic equities

  • 13:32 IST: Indian rupee appreciated by 21 paise to 72.90 against the US dollar on Monday's opening trade supported by sustained foreign fund inflows and weakness of the American currency in the overseas market. Positive domestic equities and news on COVID-19 vaccine also improved sentiments.

    India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

    The domestic unit opened at 72.93 against the US dollar at the interbank forex market, and inched higher to 72.90

    Rupee surges 21 paise to 72.90 amid weak US dollar, positive domestic equities

  • Jan 04, 2021 12:44 (IST)

    YES Bank share falls after 4 days of gain



    YES Bank share was trading marginally lower on Monday morning after  four days of straight gains, in line with other private and public banking  indices.

    The stock price of the private lender opened higher at Rs 18.40 today and gained to day's high of Rs 18.60 on BSE. Later, the stock erased early gains and fell 0.83% to an intraday low of Rs 17.90, against the last close of Rs 17.73.

     

  • 12:44 IST:

    YES Bank share was trading marginally lower on Monday morning after  four days of straight gains, in line with other private and public banking  indices.

    The stock price of the private lender opened higher at Rs 18.40 today and gained to day's high of Rs 18.60 on BSE. Later, the stock erased early gains and fell 0.83% to an intraday low of Rs 17.90, against the last close of Rs 17.73.

     

  • Jan 04, 2021 12:34 (IST)

    Seven out of 10 firms add Rs 75,845 crore in m-cap; HDFC biggest gainer

    Seven of the top-10 most valued domestic firms together added Rs 75,845.46 crore in market valuation in the past week, with HDFC twins emerging as the biggest gainers.

    Apart from HDFC duo, Tata Consultancy Services (TCS), Infosys, Kotak Mahindra Bank, ICICI Bank and Bajaj Finance were other gainers.

    On the other hand, Reliance Industries Limited (RIL), Hindustan Unilever Limited and Bharti Airtel saw erosion in their market valuation.

    Seven out of 10 firms add Rs 75,845 crore in m-cap; HDFC biggest gainer

     

  • 12:34 IST: Seven of the top-10 most valued domestic firms together added Rs 75,845.46 crore in market valuation in the past week, with HDFC twins emerging as the biggest gainers.

    Apart from HDFC duo, Tata Consultancy Services (TCS), Infosys, Kotak Mahindra Bank, ICICI Bank and Bajaj Finance were other gainers.

    On the other hand, Reliance Industries Limited (RIL), Hindustan Unilever Limited and Bharti Airtel saw erosion in their market valuation.

    Seven out of 10 firms add Rs 75,845 crore in m-cap; HDFC biggest gainer

     

  • Jan 04, 2021 12:34 (IST)

    Pfizer stock outlook

    Yash Gupta Equity Research Associate, Angel Broking said,"Pfizer stock up by 3.4% on expectation of getting approval for its covid 2019 vaccine. India to conduct its first dry run for covid 2019 vaccine on 2nd January 2020 i.e Saturday as announced by the health ministry. Earlier dry run was expected to be conducted in 4-5 states of India but now it was decided to do dry run across India. At this point of time different vaccines are in the lead for approval from the health ministry like Bharat Biotech, Serum institute of India and BioNTech. Pfizer India parent company already got approval for emergency use of vaccine for covid 2019. As per the media news India may announce emergency use of vaccines in the first week of January. Any approval for Pfizer can be very big for the company."

     

  • 12:34 IST: Yash Gupta Equity Research Associate, Angel Broking said,"Pfizer stock up by 3.4% on expectation of getting approval for its covid 2019 vaccine. India to conduct its first dry run for covid 2019 vaccine on 2nd January 2020 i.e Saturday as announced by the health ministry. Earlier dry run was expected to be conducted in 4-5 states of India but now it was decided to do dry run across India. At this point of time different vaccines are in the lead for approval from the health ministry like Bharat Biotech, Serum institute of India and BioNTech. Pfizer India parent company already got approval for emergency use of vaccine for covid 2019. As per the media news India may announce emergency use of vaccines in the first week of January. Any approval for Pfizer can be very big for the company."

     

  • Jan 04, 2021 12:14 (IST)

    Praj Industries outlook

    Yash Gupta Equity Research Associate, Angel Broking said,"Praj Industries Ltd has informed that the company has received an Order for Rs. 226.90 crores from Indian Oil Corporation Limited (IOCL), New Delhi, for execution of Zero Liquid Discharge System Water Treatment Package and Waste Water Treatment Package of Acrylic/Oxo-Alcohol Project at IOCL Dumad, Gujarat. This is a big order for the praj industry, it will help praj industry to increase its domestic market share in Hipurity business.
     

  • 12:14 IST: Yash Gupta Equity Research Associate, Angel Broking said,"Praj Industries Ltd has informed that the company has received an Order for Rs. 226.90 crores from Indian Oil Corporation Limited (IOCL), New Delhi, for execution of Zero Liquid Discharge System Water Treatment Package and Waste Water Treatment Package of Acrylic/Oxo-Alcohol Project at IOCL Dumad, Gujarat. This is a big order for the praj industry, it will help praj industry to increase its domestic market share in Hipurity business.
     

  • Jan 04, 2021 11:53 (IST)

    Covid-19 vaccine outlook

    Yash Gupta Equity Research Associate, Angel Broking said,"Covid-19 Dry run across India, another positive news for Indian market that the health ministry today asked states and union territories to conduct a dry run for the administration of vaccines on 2nd January 2020 i.e Saturday. To check and find out any loophole in the process of vaccination against covid 2019. In the dry run candidate approval is not required, after the successful dry run once candidate for initial phase is approved after that vaccine will be rolled out in India. In India two vaccines are in front lead i.e Bharat Biotech and Serum institute of India. Earlier it was decided that the dry run will only be conducted in 4 states of India but today the health ministry has decided to conduct a dry run across India. Any positive news of vaccine rollout in India will be a very positive Indian stock market."

  • 11:53 IST: Yash Gupta Equity Research Associate, Angel Broking said,"Covid-19 Dry run across India, another positive news for Indian market that the health ministry today asked states and union territories to conduct a dry run for the administration of vaccines on 2nd January 2020 i.e Saturday. To check and find out any loophole in the process of vaccination against covid 2019. In the dry run candidate approval is not required, after the successful dry run once candidate for initial phase is approved after that vaccine will be rolled out in India. In India two vaccines are in front lead i.e Bharat Biotech and Serum institute of India. Earlier it was decided that the dry run will only be conducted in 4 states of India but today the health ministry has decided to conduct a dry run across India. Any positive news of vaccine rollout in India will be a very positive Indian stock market."

  • Jan 04, 2021 11:15 (IST)

    Nifty Pharma index outlook

    . Yash Gupta Equity Research Associate, Angel Broking said," Nifty Pharma index best performing index in '2020, will 2021 be in the same line?bNifty Pharma index has gained more than 60% in 2020 and more than 108% from march lows and ended in green after 5 years of down fall, Nifty Pharma index ended at 12916 at near previous life time highs which made in 2015. There are several rationales behind the bull run in pharma index like domestic & Export market pick up the sales growth momentum, Anti-infectives segment done well due to benefit related to covid and increase in product launches in the Export market.

     

    We expect pharma to continue its bull run in 2021, we expect export business to do much better than domestic business as Product link incentive (PLI) scheme to boost the export with in next 2-3 years, Indian pharma company to get some benefit of anti-china sentiments after covid, along with this healthy pipeline of approved ANDA from USFDA.

     

    We continue to be bullish on the pharma sector and expect it to do well in 2021.

    In the pharma sector our pick for 2021 will be Cadila healthcare Ltd and we suggest investors to be cautious on mid & small cap pharma companies."

  • 11:15 IST: . Yash Gupta Equity Research Associate, Angel Broking said," Nifty Pharma index best performing index in '2020, will 2021 be in the same line?bNifty Pharma index has gained more than 60% in 2020 and more than 108% from march lows and ended in green after 5 years of down fall, Nifty Pharma index ended at 12916 at near previous life time highs which made in 2015. There are several rationales behind the bull run in pharma index like domestic & Export market pick up the sales growth momentum, Anti-infectives segment done well due to benefit related to covid and increase in product launches in the Export market.

     

    We expect pharma to continue its bull run in 2021, we expect export business to do much better than domestic business as Product link incentive (PLI) scheme to boost the export with in next 2-3 years, Indian pharma company to get some benefit of anti-china sentiments after covid, along with this healthy pipeline of approved ANDA from USFDA.

     

    We continue to be bullish on the pharma sector and expect it to do well in 2021.

    In the pharma sector our pick for 2021 will be Cadila healthcare Ltd and we suggest investors to be cautious on mid & small cap pharma companies."

  • Jan 04, 2021 10:51 (IST)

    Adani Green Energy share price gains 2% today




    Adani Green Energy stock touched an intraday high of Rs 1088 (2.05%) after the company received letter of award for 600 MW wind-solar hybrid power project. Adani Green is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.Stock has been gaining for the last 6 days and has risen 3.67% returns in the period.

  • 10:51 IST:


    Adani Green Energy stock touched an intraday high of Rs 1088 (2.05%) after the company received letter of award for 600 MW wind-solar hybrid power project. Adani Green is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.Stock has been gaining for the last 6 days and has risen 3.67% returns in the period.

  • Jan 04, 2021 10:42 (IST)

    Top gainers

    TCS, ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank were among the gainers. On the other hand, HDFC, Asian Paints and Reliance Industries were among the laggards.

     

  • 10:42 IST: TCS, ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank were among the gainers. On the other hand, HDFC, Asian Paints and Reliance Industries were among the laggards.

     

  • Jan 04, 2021 10:30 (IST)

    GTPL Hathway share trades tad lower



    GTPL Hathway share was trading tad lower after the company sold its entire 51% stake in GTPL Shiv Network for Rs 20 lakh share transfer agreement.

    GTPL Hathway share trades 2.05% away from 52 week high of Rs 139.6. Stock has fallen after 3 days of consecutive gain. GTPL Hathway is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages

  • 10:30 IST:

    GTPL Hathway share was trading tad lower after the company sold its entire 51% stake in GTPL Shiv Network for Rs 20 lakh share transfer agreement.

    GTPL Hathway share trades 2.05% away from 52 week high of Rs 139.6. Stock has fallen after 3 days of consecutive gain. GTPL Hathway is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages

  • Jan 04, 2021 10:20 (IST)

    Power Finance Corporation share rises 2%





    Power Finance Corporation share was trading 2% higher today after the company said its borrowing plan for FY21 has been revised from Rs 90,000 crore to Rs 1,18,000 crore to accommodate the moratorium granted to borrowers as per RBI guidelines.

    Stock has been gaining for the last 2 days and has risen 2.14% returns in the period. The stock has traded in a narrow range of Rs 1.15. Power Fin.Corpn. is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages
     

  • 10:20 IST:



    Power Finance Corporation share was trading 2% higher today after the company said its borrowing plan for FY21 has been revised from Rs 90,000 crore to Rs 1,18,000 crore to accommodate the moratorium granted to borrowers as per RBI guidelines.

    Stock has been gaining for the last 2 days and has risen 2.14% returns in the period. The stock has traded in a narrow range of Rs 1.15. Power Fin.Corpn. is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages
     

  • Jan 04, 2021 10:11 (IST)

    Dilip Buildcon share up 1%

    Dilip Buildcon share was trading 1% higher at Rs 402 today after the company announced that its highway project in Karnataka has been provisionally completed and it is entitled to receive the bonus of Rs 8.84 crore in lieu of early completion.

    Stock has been gaining for the last 2 days and has risen 1.66% returns in the period. Dilip Buildcon is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages

  • 10:11 IST: Dilip Buildcon share was trading 1% higher at Rs 402 today after the company announced that its highway project in Karnataka has been provisionally completed and it is entitled to receive the bonus of Rs 8.84 crore in lieu of early completion.

    Stock has been gaining for the last 2 days and has risen 1.66% returns in the period. Dilip Buildcon is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages

  • Jan 04, 2021 09:55 (IST)

    Nifty technical outlook


    On markets opening --Manish Hathiramani, proprietary index trader and technical analyst, Deen Dayal Investments said," 14100 can pose a resistance for the Nifty. Traders should consider booking profits at the current juncture and trail thereafter. We have a good support at 13900 and if we close below this level, there could be a correction. Hence it is advised to be cautiously long with strict stops."

     

  • 09:55 IST:
    On markets opening --Manish Hathiramani, proprietary index trader and technical analyst, Deen Dayal Investments said," 14100 can pose a resistance for the Nifty. Traders should consider booking profits at the current juncture and trail thereafter. We have a good support at 13900 and if we close below this level, there could be a correction. Hence it is advised to be cautiously long with strict stops."

     

  • Jan 04, 2021 09:47 (IST)

    Market outlook

    Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services said,"Positive economic data like all-time record GST collections (Rs 1.15 lakh crores) and impressive auto numbers particularly in crucial segments like HCVs & MCVs in December augur well for the markets. The low-interest-rate has become a major tailwind for the economy. Indian economy can grow by above 10 % in FY 22. This means around 16 % increase in nominal GDP and impressive growth in corporate profits. Low-interest rate regime in the developed world and the declining dollar are positives for capital inflows into EMs like India. The risk is something triggering capital outflows which can cause a sharp correction in markets.

  • 09:47 IST: Dr. V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services said,"Positive economic data like all-time record GST collections (Rs 1.15 lakh crores) and impressive auto numbers particularly in crucial segments like HCVs & MCVs in December augur well for the markets. The low-interest-rate has become a major tailwind for the economy. Indian economy can grow by above 10 % in FY 22. This means around 16 % increase in nominal GDP and impressive growth in corporate profits. Low-interest rate regime in the developed world and the declining dollar are positives for capital inflows into EMs like India. The risk is something triggering capital outflows which can cause a sharp correction in markets.

  • Jan 04, 2021 09:45 (IST)

    Stocks to watch today on January 4

    Coal India, Hero MotoCorp, RCF, Cadila, BEML, TVS Motors among others are the top stocks to watch out for in Monday's  trading session

    Stocks in news: Coal India, Hero MotoCorp, RCF, Cadila, BEML, TVS Motors

     

  • 09:45 IST:

    Coal India, Hero MotoCorp, RCF, Cadila, BEML, TVS Motors among others are the top stocks to watch out for in Monday's  trading session

    Stocks in news: Coal India, Hero MotoCorp, RCF, Cadila, BEML, TVS Motors

     

  • Jan 04, 2021 09:44 (IST)

    Opening session

    Market indices continued to surge to new record highs on Monday in line with positive global equities. Extending gains for the ninth consecutive session, Sensex was trading 250 points higher at 48,129 and Nifty gained by 80 points higher at 14,100. During today's session, Sensex hit a lifetime high of 48,168 and Nifty rose to a new high of 14,107. Market opened at new highs today, following news that Drugs Controller General of India (DCGI) on January 3 reportedly granted restricted emergency use authorisation for the Serum Institute of India (SII)'s 'Covishield' and Bharat Biotech's 'Covaxin' vaccines against COVID-19.

  • 09:44 IST: Market indices continued to surge to new record highs on Monday in line with positive global equities. Extending gains for the ninth consecutive session, Sensex was trading 250 points higher at 48,129 and Nifty gained by 80 points higher at 14,100. During today's session, Sensex hit a lifetime high of 48,168 and Nifty rose to a new high of 14,107. Market opened at new highs today, following news that Drugs Controller General of India (DCGI) on January 3 reportedly granted restricted emergency use authorisation for the Serum Institute of India (SII)'s 'Covishield' and Bharat Biotech's 'Covaxin' vaccines against COVID-19.

  • Jan 04, 2021 09:10 (IST)

    Market outlook

    Vinod Nair, Head of Research at Geojit Financial Services said, "With a hope that 2021 will be a year of economic recovery, the market is touching all-time highs on a daily basis. Stocks across sectors cheered with mid & small caps at the forefront. The combined effect of foreign inflows and real earnings growth can keep the market rallying going forward"


    S Ranganathan, Head of Research at LKP Securities said,"Markets ended in the Green on the First Day of the New Year buoyed by record GST collections and we saw a host of stocks buzzing around in the broader market weeks ahead of the Earnings Season. TCS led the rally with the Auto numbers providing the momentum as a number of companies announced  price hikes today.

  • 09:10 IST: Vinod Nair, Head of Research at Geojit Financial Services said, "With a hope that 2021 will be a year of economic recovery, the market is touching all-time highs on a daily basis. Stocks across sectors cheered with mid & small caps at the forefront. The combined effect of foreign inflows and real earnings growth can keep the market rallying going forward"


    S Ranganathan, Head of Research at LKP Securities said,"Markets ended in the Green on the First Day of the New Year buoyed by record GST collections and we saw a host of stocks buzzing around in the broader market weeks ahead of the Earnings Season. TCS led the rally with the Auto numbers providing the momentum as a number of companies announced  price hikes today.

  • Jan 04, 2021 09:08 (IST)

    COVID vaccine


    Meanwhile, the Drugs Controller General of India (DCGI) on January 3 reportedly granted restricted emergency use authorisation for the Serum Institute of India (SII)'s ‘Covishield' and Bharat Biotech's ‘Covaxin' vaccines against COVID-19, the disease caused by the novel coronavirus. The ‘Covishield' vaccine, developed by University of Oxford and pharmaceutical giant AstraZeneca, is being produced in the country by the Serum Institute. Bharat Biotech has developed ‘Covaxin' – India's first indigenous vaccine against COVID-19.



     

  • 09:08 IST:
    Meanwhile, the Drugs Controller General of India (DCGI) on January 3 reportedly granted restricted emergency use authorisation for the Serum Institute of India (SII)'s ‘Covishield' and Bharat Biotech's ‘Covaxin' vaccines against COVID-19, the disease caused by the novel coronavirus. The ‘Covishield' vaccine, developed by University of Oxford and pharmaceutical giant AstraZeneca, is being produced in the country by the Serum Institute. Bharat Biotech has developed ‘Covaxin' – India's first indigenous vaccine against COVID-19.



     

  • Jan 04, 2021 09:07 (IST)

    FII action

    Foreign portfolio investors (FPIs) bought shares worth Rs 506.21 crore, while domestic institutional investors (DIIs), were net buyers to the tune of Rs 69.40 crore in the Indian equity market on 1 January, provisional data showed.

     


     

  • 09:07 IST:

    Foreign portfolio investors (FPIs) bought shares worth Rs 506.21 crore, while domestic institutional investors (DIIs), were net buyers to the tune of Rs 69.40 crore in the Indian equity market on 1 January, provisional data showed.

     


     

  • Jan 04, 2021 09:05 (IST)

    Closing on Friday

    Market indices closed on a positive note on Friday, the first session of the year amid robust buying in IT, auto and FMCG stocks. Extending gains for the eighth consecutive session, Sensex ended 117 points higher at 47,868 and Nifty closed 36 points higher at 14,018. During today's session, Sensex hit a lifetime high of 47,980 and Nifty rose to a new high of 14,049.

    On the currency front, after rising for six straight sessions, the Indian rupee traded in a narrow range and depreciated by 4 paise to close at 73.11 against the US dollar in the first session 2021. Market participants remained on the sidelines due to lack of fresh cues. Forex traders said the momentum for the currency is likely to stay low as no major economic data is expected to release on the domestic as well as on the global front.

     

  • 09:05 IST: Market indices closed on a positive note on Friday, the first session of the year amid robust buying in IT, auto and FMCG stocks. Extending gains for the eighth consecutive session, Sensex ended 117 points higher at 47,868 and Nifty closed 36 points higher at 14,018. During today's session, Sensex hit a lifetime high of 47,980 and Nifty rose to a new high of 14,049.

    On the currency front, after rising for six straight sessions, the Indian rupee traded in a narrow range and depreciated by 4 paise to close at 73.11 against the US dollar in the first session 2021. Market participants remained on the sidelines due to lack of fresh cues. Forex traders said the momentum for the currency is likely to stay low as no major economic data is expected to release on the domestic as well as on the global front.